サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：細胞株開発の世界市場規模：タイプ別、製品別、由来別、地域別の予測（2022年～2028年）
市場調査レポート
商品コード
1073696

細胞株開発の世界市場規模：タイプ別、製品別、由来別、地域別の予測（2022年～2028年）

Global Cell Line Development Market Size study, by Type (Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines), by Product (Equipment, Media and Reagents), by Source (Mammalians) and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
細胞株開発の世界市場規模：タイプ別、製品別、由来別、地域別の予測（2022年～2028年）
出版日: 2022年04月30日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞株開発の市場規模は、2022年～2028年の予測期間中に健全な成長率で成長すると予想されています。

市場成長の主な要因は、モノクローナル抗体の需要の増加、病院のインフラへの投資の増加です。また、パンデミックや感染症のリスクの高まりに伴う細胞株開発の採用と需要が、予測期間中の市場成長を後押しすると予想されます。しかし、安定した信頼できる細胞株の開発が、予測期間中の市場成長の妨げとなっています。

当レポートでは、世界の細胞株開発市場について調査分析し、市場動向、業界分析、COVID-19の影響、セグメント別・地域別の市場分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の細胞株開発市場の定義と範囲

第3章 世界の細胞株開発市場力学

  • 細胞株開発市場の影響分析（2020年～2028年）

第4章 世界の細胞株開発市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的影響の評価
    • COVID-19前・COVID-19後の市場シナリオ

第6章 世界の細胞株開発市場：タイプ別

  • 市場スナップショット
  • 実績 - 潜在性分析
  • 推定と予測（2019年～2028年）
  • サブセグメント分析
    • 一次細胞株
    • 連続細胞株
    • ハイブリドーマ
    • 組換え細胞株

第7章 世界の細胞株開発市場：製品別

  • 市場スナップショット
  • 実績 - 潜在性分析
  • 推定と予測（2019年～2028年）
  • サブセグメント分析
    • 装置
    • 媒体・試薬

第8章 世界の細胞株開発市場：由来別

  • 市場スナップショット
  • 実績 - 潜在性分析
  • 推定と予測（2019年～2028年）
  • サブセグメント分析
    • 哺乳類

第9章 世界の細胞株開発市場：地域別の分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Sartorius AG(Germany)
    • American Type Culture Collection(ATCC)(U.S.)
    • Lonza Group AG(Switzerland)
    • Thermo Fisher Scientific, Inc.(U.S.)
    • GE Healthcare(U.K.)
    • Sigma Aldrich Corporation(U.S.)
    • Selexis SA(Switzerland)
    • European Collection of Cell Cultures(ECACC)(U.K.)
    • Corning, Inc.(U.S.)
    • Wuxi App Tec, Inc.(China)

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Cell Line Development market, report scope
  • TABLE 2. Global Cell Line Development market estimates & forecasts by Region 2019-2028 (USD Billion)
  • TABLE 3. Global Cell Line Development market estimates & forecasts by Type 2019-2028 (USD Billion)
  • TABLE 4. Global Cell Line Development market estimates & forecasts by Product 2019-2028 (USD Billion)
  • TABLE 5. Global Cell Line Development market estimates & forecasts by Source 2019-2028 (USD Billion)
  • TABLE 6. Global Cell Line Development market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 7. Global Cell Line Development market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 8. Global Cell Line Development market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 9. Global Cell Line Development market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 10. Global Cell Line Development market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 11. Global Cell Line Development market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 12. Global Cell Line Development market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 13. Global Cell Line Development market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 14. Global Cell Line Development market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 15. Global Cell Line Development market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 16. U.S. Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 17. U.S. Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 18. U.S. Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 19. Canada Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 20. Canada Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 21. Canada Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 22. UK Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 23. UK Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 24. UK Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 25. Germany Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 26. Germany Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 27. Germany Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 28. RoE Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 29. RoE Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 30. RoE Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 31. China Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 32. China Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 33. China Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 34. India Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 35. India Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 36. India Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 37. Japan Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 38. Japan Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 39. Japan Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 40. RoAPAC Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 41. RoAPAC Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 42. RoAPAC Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 43. Brazil Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 44. Brazil Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 45. Brazil Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 46. Mexico Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 47. Mexico Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 48. Mexico Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 49. RoLA Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 50. RoLA Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 51. RoLA Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 52. Row Cell Line Development market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 53. Row Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 54. Row Cell Line Development market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Cell Line Development market
  • TABLE 56. List of primary sources, used in the study of global Cell Line Development market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Cell Line Development market, research methodology
  • FIG 2. Global Cell Line Development market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Cell Line Development market, key trends 2021
  • FIG 5. Global Cell Line Development market, growth prospects 2022-2028
  • FIG 6. Global Cell Line Development market, porters 5 force model
  • FIG 7. Global Cell Line Development market, pest analysis
  • FIG 8. Global Cell Line Development market, value chain analysis
  • FIG 9. Global Cell Line Development market by segment, 2019 & 2028 (USD Billion)
  • FIG 10. Global Cell Line Development market by segment, 2019 & 2028 (USD Billion)
  • FIG 11. Global Cell Line Development market by segment, 2019 & 2028 (USD Billion)
  • FIG 12. Global Cell Line Development market by segment, 2019 & 2028 (USD Billion)
  • FIG 13. Global Cell Line Development market by segment, 2019 & 2028 (USD Billion)
  • FIG 14. Global Cell Line Development market, regional snapshot 2019 & 2028
  • FIG 15. North America Cell Line Development market 2019 & 2028 (USD Billion)
  • FIG 16. Europe Cell Line Development market 2019 & 2028 (USD Billion)
  • FIG 17. Asia pacific Cell Line Development market 2019 & 2028 (USD Billion)
  • FIG 18. Latin America Cell Line Development market 2019 & 2028 (USD Billion)
  • FIG 19. Global Cell Line Development market, company market share analysis (2021)
目次

Global Cell Line Development Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Cell Line Development is the process by which the cellular machinery is co-opted to manufacture therapeutic biologics or other proteins of interest. Increasing demand for monoclonal antibodies, increase investment in hospital infrastructure has led to the adoption of Cell Line Development across the forecast period. For Instance: As per the IBEF, The hospital industry in India is forecast to increase to Rs. 8.6 trillion (US$ 132.84 billion) by FY22 from Rs. 4 trillion (US$ 61.79 billion) in FY17 at a CAGR of 16-17%. Also, with the increasing risk of pandemic and communicable diseases, the adoption & demand for Cell Line Development is likely to increase the market growth during the forecast period. However, developing stable and authentic cell lines impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Cell Line Development market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to increased demand for monoclonal antibodies, rising vaccine production, and the use of innovative technologies. Whereas, North-America is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as increasing demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies would create lucrative growth prospects for the Cell Line Development market across North America region.

Major market players included in this report are:

Sartorius AG (Germany)

American Type Culture Collection (ATCC) (U.S.)

Lonza Group AG (Switzerland)

Thermo Fisher Scientific, Inc. (U.S.)

GE Healthcare (U.K.)

Sigma Aldrich Corporation (U.S.)

Selexis SA (Switzerland)

European Collection of Cell Cultures (ECACC) (U.K.)

Corning, Inc. (U.S.)

Wuxi App Tec, Inc. (China)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Primary Cell Lines

Continuous Cell Lines

Hybridomas

Recombinant Cell Lines

By Product:

Equipment

Media and Reagents

By Source:

Mammalians

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Cell Line Development Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Global Cell Line Development Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Global Cell Line Development Market, by Type, 2020-2028 (USD Billion)
    • 1.2.3. Global Cell Line Development Market, by Product, 2020-2028 (USD Billion)
    • 1.2.4. Global Cell Line Development Market, by Source, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cell Line Development Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cell Line Development Market Dynamics

  • 3.1. Cell Line Development Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing demand for monoclonal antibodies
      • 3.1.1.2. Increasing investment in hospital infrastructure
    • 3.1.2. Market Challenges
      • 3.1.2.1. Developing Stable and Authentic Cell Lines
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing risk of pandemic and communicable diseases

Chapter 4. Global Cell Line Development Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Cell Line Development Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Cell Line Development Market by Type, Performance - Potential Analysis
  • 6.3. Global Cell Line Development Market Estimates & Forecasts by Type, 2019-2028 (USD Billion)
  • 6.4. Cell Line Development Market, Sub Segment Analysis
    • 6.4.1. Primary Cell Lines
    • 6.4.2. Continuous Cell Lines
    • 6.4.3. Hybridomas
    • 6.4.4. Recombinant Cell Lines

Chapter 7. Global Cell Line Development Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Cell Line Development Market by Product, Performance - Potential Analysis
  • 7.3. Global Cell Line Development Market Estimates & Forecasts by Product, 2019-2028 (USD Billion)
  • 7.4. Cell Line Development Market, Sub Segment Analysis
    • 7.4.1. Equipment
    • 7.4.2. Media and Reagents

Chapter 8. Global Cell Line Development Market, by Source

  • 8.1. Market Snapshot
  • 8.2. Global Cell Line Development Market by Source, Performance - Potential Analysis
  • 8.3. Global Cell Line Development Market Estimates & Forecasts by Source, 2019-2028 (USD Billion)
  • 8.4. Cell Line Development Market, Sub Segment Analysis
    • 8.4.1. Mammalians

Chapter 9. Global Cell Line Development Market, Regional Analysis

  • 9.1. Cell Line Development Market, Regional Market Snapshot
  • 9.2. North America Cell Line Development Market
    • 9.2.1. U.S. Cell Line Development Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2028
      • 9.2.1.2. Product breakdown estimates & forecasts, 2019-2028
      • 9.2.1.3. Source breakdown estimates & forecasts, 2019-2028
    • 9.2.2. Canada Cell Line Development Market
  • 9.3. Europe Cell Line Development Market Snapshot
    • 9.3.1. U.K. Cell Line Development Market
    • 9.3.2. Germany Cell Line Development Market
    • 9.3.3. France Cell Line Development Market
    • 9.3.4. Spain Cell Line Development Market
    • 9.3.5. Italy Cell Line Development Market
    • 9.3.6. Rest of Europe Cell Line Development Market
  • 9.4. Asia-Pacific Cell Line Development Market Snapshot
    • 9.4.1. China Cell Line Development Market
    • 9.4.2. India Cell Line Development Market
    • 9.4.3. Japan Cell Line Development Market
    • 9.4.4. Australia Cell Line Development Market
    • 9.4.5. South Korea Cell Line Development Market
    • 9.4.6. Rest of Asia Pacific Cell Line Development Market
  • 9.5. Latin America Cell Line Development Market Snapshot
    • 9.5.1. Brazil Cell Line Development Market
    • 9.5.2. Mexico Cell Line Development Market
  • 9.6. Rest of The World Cell Line Development Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Sartorius AG (Germany)
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. American Type Culture Collection (ATCC) (U.S.)
    • 10.2.3. Lonza Group AG (Switzerland)
    • 10.2.4. Thermo Fisher Scientific, Inc. (U.S.)
    • 10.2.5. GE Healthcare (U.K.)
    • 10.2.6. Sigma Aldrich Corporation (U.S.)
    • 10.2.7. Selexis SA (Switzerland)
    • 10.2.8. European Collection of Cell Cultures (ECACC) (U.K.)
    • 10.2.9. Corning, Inc. (U.S.)
    • 10.2.10. Wuxi App Tec, Inc. (China)

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption